Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Acumen Pharmaceuticals, Inc.

NASDAQ: ABOS · Life Sciences · 5 alerts · CIK 1576885

Share price
$0.2160Close, Nov 16
Market cap
$15.6M
Shares outstanding
72.33MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Acumen Pharmaceuticals, Inc. filings on SEC EDGAR ↗

9:27 AM ET 8-K
Investor Presentation

Acumen Pharmaceuticals Investor Presentation

Acumen Pharmaceuticals is hosting an Investor Day on September 16, 2026, to discuss its strategic goals and clinical pipeline, including its product candidate sabirnetug (ACU193) for Alzheimer's Disease. The presentation covers the Phase 2 ALTITUDE-AD study, potential subcutaneous dosing options, and the company's Enhanced Brain Delivery (EBD) technology with a planned IND filing in mid-2027.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.